Latest news and video coverage curated from trusted media outlets
Paralympics 2020: Vinod Kumar bags bronze and Nishad Kumar clinches silver medal | Oneindia News
Credit: Oneindia Duration: 04:27Published
Mixing vaccines study gets DCGI nod | Are 2 different vaccines better than 1? | Oneindia News
Credit: Oneindia Duration: 01:46Published
Joe Biden urges Afghan leaders to fight against Taliban | Withdrawing US troops | Oneindia News
Credit: Oneindia Duration: 02:26Published
ICMR study suggests mixing Covaxin and Covishield can work better against Covid-19 | Oneindia News
Credit: Oneindia Duration: 01:17Published
Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News
Credit: Oneindia Duration: 03:00Published
Covid-19: Govt panel backs mixing Covishield and Covaxin| Oneindia News
Credit: Oneindia Duration: 01:48Published
You Might Like
WHO`s emergency use authorization to Covaxin expected soon: MoS Health Dr Bharati Pravin Pawar“WHO's emergency use authorization to Covaxin is expected soon,” Dr Bharati Pravin Pawar, MoS, Health, was quoted as saying by news agency ANI.
Government ducks question on WHO Covaxin approval
Bharat Biotech completes Covaxin phase 2/3 trials in childrenBharat Biotech has completed the Phase II/III clinical trials of Covaxin on children in the 2-18 years age group and is all set to submit the data to the Drugs Controller General of India (DCGI), the..
Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairmanCovaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr Krishna Ella said on Tuesday. Pointing..
Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials
Covaxin kids trial over, Bharat Biotech to submit data to DCGI next week
WHO emergency use authorisation to Covaxin delayed till October 5
Also reported by •Zee News
Bharat Biotech awaits feedback from WHO for Covaxin EUL
Also reported by •newKerala.com •IndiaTimes
Covaxin may soon get WHO approval as expert group scheduled to meet next monthSAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
Covaxin may get WHO approval by month-end, says NITI Aayog
Also reported by •DNA
Close to a decision point, says Dr V K Paul on WHO Emergency Use Listing to Covaxin
WHO’s approval for Covaxin likely this month
Also reported by •IndiaTimes
Positive decision could be coming in before September-end: Niti Aayog Member VK Paul on WHO nod for Covaxin"We know of positive developments - data sharing, data evaluation going on through multiple reviews and we know that we're close to a decision point," VK Paul said.
COVID-19: WHO approval for Covaxin expected this week: Sources
COVID-19: Bharat Biotech`s Covaxin likely to get WHO nod this weekLast month, Union Health Minister Mansukh Mandaviya had met WHO Chief Scientist Dr Soumya Swaminathan and had discussed over the global health body's approval for the homegrown COVID-19 vaccine.
Centre says two doses of Covaxin must even for Covid-cured peopleA person must take two doses of the anti-Covid vaccine, Covaxin, even after recovering from Covid-19, for being considered as a fully vaccinated individual, a Union health ministry official said on..
Do you know how to identify fake Covishield, Covaxin, Sputnik V COVID-19 vaccines? Check hereThis comes amid the WHO flagging concern over counterfeit/falsified Covishield vaccine being found in the South-East Asia and Africa region.
Covishield, Covaxin & Sputnik V: You can now identify COVID-19 fake vaccines with these stepsIndia is currently administering 3 vaccines - Covidshield, Covaxin and Sputnik V. Here are some ways in which you can identify if the vaccine is fake
Bharat Biotech rolls out first batch of Covaxin from Ankleshwar in GujaratIn a move that will augment the supply of indigenously developed Covid-19 vaccine Covaxin, Bharat Biotech has announced the rollout of the first commercial batch of Covaxin from its Chiron Behring..
First batch of Covaxin rolls out of Gujarat plant of Bharat Biotech
Health Minister Mandaviya launches 1st commercial batch of Bharat Biotech's COVAXIN manufactured in Ankleshwar
Mandaviya releases 1st commercial batch of Covaxin from Bharat Biotech's new plant
Also reported by •IndiaTimes •Zee News
1 Covaxin dose to survivor equals 2 doses to uninfectedA single-dose of Bharat Biotech’s Covaxin in people who had been infected with Covid-19 previously generates antibody response similar to that provided by two doses of the vaccine in those without..
Single Covaxin jab in previously COVID infected individuals equivalent to two doses in infection-naive persons: Study
Covaxin single-dose to Covid infected equivalent to 2 doses for unaffected: ICMR
Also reported by •IndiaTimes
ICMR study reveals how single Covaxin jab can be equivalent to two doses for special casesA new study by ICMR has shown how a single Covaxin jab can be equivalent to two doses of the vaccine in previously COVID infected people.
If previously COVID-19 infected, single Covaxin dose draws same antibody response as two doses: ICMR study
No proposal to change Covishield, Covaxin, and Sputnik V dose Interval: NTAGI Chief Dr Nk Arora
Majority Indians experienced no or mild side effects post 2 doses of Covishield and Covaxin: Report
Covaxin, Covishield trial participants to get vax certificate
'Covaxin for children may get DGCI nod before trial period'
Mumbai to resume COVID-19 vaccination today after 2-day halt, check list of CVCs administering vaccinesThe Brihanmumbai Municipal Corporation (BMC) informed that it has received 1,50,000 doses of Covishield and 10,240 doses of Covaxin.
Over 1.5 lakh vaccine doses arrive in Mumbai, drive to resume on Saturday: BMCIn a statement issued on Friday, the BMC said 1,60,240 vaccine doses arrived here on Thursday night, comprising 1.5 lakh Covishield and 10,240 Covaxin vaccines
Covid vaccination for kids may start only by March ’22Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine..
Kerala man files plea in court for Covishield after taking both doses of Covaxin, read whyThe man Girikumar, 50 had filed a plea in the Kerala High Court stating that he works in Saudi Arabia which is yet to recognise the Covaxin.
When will India have COVID-19 vaccines for children? ICMR-NIV Director answersCurrently, Phase II and III trials of Bharat Biotech's Covaxin are going on for children in the age group of 2-18 years.
‘Inactivated vaccines don’t have good reputation but Covaxin data looks promising’: Expert
Is mixing two COVID-19 vaccines unsafe?As per the ICMR study, the mixing of two vaccines (covidshield and covaxin) is safe and provides better immunity.